Rare diseases
Investigational molecules
Locations
Back to Czechia10 clinical trials in Prerov, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
CzechiaStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
CzechiaStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
CzechiaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaStudy on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein reduction and cardiovascular event prevention in patients with established heart conditions.
Advanced clinical investigations evaluating new therapeutic approaches for improving cardiovascular outcomes.
Studies examining innovative treatments for hypercholesterolemia and their impact on patient quality of life.
Research focused on developing effective strategies for managing cholesterol levels in high-risk patients.
Comprehensive studies investigating combination therapies for patients with heart failure and concurrent kidney function impairment.
Innovative research exploring dual-therapy approaches for complex cardiovascular conditions.
Clinical trials examining primary prevention strategies for atherosclerotic cardiovascular disease in high-risk populations.
Forward-looking research aimed at preventing cardiovascular complications before they develop.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
